|
|
|
|
LEADER |
00993nas a2200253 u 4500 |
001 |
10028035 |
003 |
upatras |
005 |
20210117195636.0 |
008 |
750907s1909 us m p eng |
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 21579
|a LISP
|b LISP
|c SER
|d 2016-04-24
|i 828
|l 0
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y JNL
|
999 |
|
|
|c 12929
|d 12929
|
022 |
|
|
|a 0022-3565
|
040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
041 |
0 |
|
|a eng
|
082 |
0 |
4 |
|a 615.1
|
110 |
|
0 |
|a American Society for Pharmacology and Experimental Therapeutics
|9 24641
|
222 |
|
0 |
|a Journal of pharmacology and experimental therapeutics
|b [Περιοδικό]
|
245 |
1 |
0 |
|a Journal of pharmacology and experimental therapeutics
|h [Περιοδικό]
|
260 |
|
|
|a Baltimore
|b Williams & Wilkins
|
310 |
|
|
|a Μηνιαίο
|
362 |
0 |
|
|a 212(1980) -
|
852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b B
|k ΠΕΡ
|m 828
|t 1
|3 212(1980)-
|3 Vol.291:No.1(1999:OCT)-Vol.339:No.3(2011:DEC)
|
866 |
|
|
|a 212(1980)-
|a Vol.291:No.1(1999:OCT)-Vol.339:No.3(2011:DEC)
|
942 |
|
|
|2 ddc
|s 1
|c JNL
|